symbol,statement_type,period_end,line_item,value
TATACHEM.NS,income,2025-03-31 00:00:00,Tax Effect Of Unusual Items,-400671785.028791
TATACHEM.NS,income,2025-03-31 00:00:00,Tax Rate For Calcs,0.320537
TATACHEM.NS,income,2025-03-31 00:00:00,Normalized EBITDA,23320000000.0
TATACHEM.NS,income,2025-03-31 00:00:00,Total Unusual Items,-1250000000.0
TATACHEM.NS,income,2025-03-31 00:00:00,Total Unusual Items Excluding Goodwill,-1250000000.0
TATACHEM.NS,income,2025-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,2020000000.0
TATACHEM.NS,income,2025-03-31 00:00:00,Reconciled Depreciation,11230000000.0
TATACHEM.NS,income,2025-03-31 00:00:00,Reconciled Cost Of Revenue,52990000000.0
TATACHEM.NS,income,2025-03-31 00:00:00,EBITDA,22070000000.0
TATACHEM.NS,income,2025-03-31 00:00:00,EBIT,10840000000.0
TATACHEM.NS,income,2025-03-31 00:00:00,Net Interest Income,-5630000000.0
TATACHEM.NS,income,2025-03-31 00:00:00,Interest Expense,5630000000.0
TATACHEM.NS,income,2025-03-31 00:00:00,Interest Income,
TATACHEM.NS,income,2025-03-31 00:00:00,Normalized Income,2869328214.971209
TATACHEM.NS,income,2025-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,2350000000.0
TATACHEM.NS,income,2025-03-31 00:00:00,Total Expenses,140570000000.0
TATACHEM.NS,income,2025-03-31 00:00:00,Rent Expense Supplemental,
TATACHEM.NS,income,2025-03-31 00:00:00,Diluted Average Shares,
TATACHEM.NS,income,2025-03-31 00:00:00,Basic Average Shares,
TATACHEM.NS,income,2025-03-31 00:00:00,Diluted EPS,
TATACHEM.NS,income,2025-03-31 00:00:00,Basic EPS,
TATACHEM.NS,income,2025-03-31 00:00:00,Diluted NI Availto Com Stockholders,2350000000.0
TATACHEM.NS,income,2025-03-31 00:00:00,Net Income Common Stockholders,2350000000.0
TATACHEM.NS,income,2025-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
TATACHEM.NS,income,2025-03-31 00:00:00,Net Income,2350000000.0
TATACHEM.NS,income,2025-03-31 00:00:00,Minority Interests,-1520000000.0
TATACHEM.NS,income,2025-03-31 00:00:00,Net Income Including Noncontrolling Interests,3870000000.0
TATACHEM.NS,income,2025-03-31 00:00:00,Net Income Discontinuous Operations,330000000.0
TATACHEM.NS,income,2025-03-31 00:00:00,Net Income Continuous Operations,3540000000.0
TATACHEM.NS,income,2025-03-31 00:00:00,Tax Provision,1670000000.0
TATACHEM.NS,income,2025-03-31 00:00:00,Pretax Income,5210000000.0
TATACHEM.NS,income,2025-03-31 00:00:00,Other Non Operating Income Expenses,2250000000.0
TATACHEM.NS,income,2025-03-31 00:00:00,Special Income Charges,-1250000000.0
TATACHEM.NS,income,2025-03-31 00:00:00,Other Special Charges,1250000000.0
TATACHEM.NS,income,2025-03-31 00:00:00,Write Off,
TATACHEM.NS,income,2025-03-31 00:00:00,Impairment Of Capital Assets,
TATACHEM.NS,income,2025-03-31 00:00:00,Restructuring And Mergern Acquisition,
TATACHEM.NS,income,2025-03-31 00:00:00,Net Non Operating Interest Income Expense,-5630000000.0
TATACHEM.NS,income,2025-03-31 00:00:00,Total Other Finance Cost,
TATACHEM.NS,income,2025-03-31 00:00:00,Interest Expense Non Operating,5630000000.0
TATACHEM.NS,income,2025-03-31 00:00:00,Interest Income Non Operating,
TATACHEM.NS,income,2025-03-31 00:00:00,Operating Income,8300000000.0
TATACHEM.NS,income,2025-03-31 00:00:00,Operating Expense,87580000000.0
TATACHEM.NS,income,2025-03-31 00:00:00,Other Operating Expenses,29100000000.0
TATACHEM.NS,income,2025-03-31 00:00:00,Depreciation And Amortization In Income Statement,11230000000.0
TATACHEM.NS,income,2025-03-31 00:00:00,Amortization,
TATACHEM.NS,income,2025-03-31 00:00:00,Depreciation Income Statement,11230000000.0
TATACHEM.NS,income,2025-03-31 00:00:00,Selling General And Administration,27360000000.0
TATACHEM.NS,income,2025-03-31 00:00:00,Selling And Marketing Expense,27360000000.0
TATACHEM.NS,income,2025-03-31 00:00:00,General And Administrative Expense,
TATACHEM.NS,income,2025-03-31 00:00:00,Rent And Landing Fees,
TATACHEM.NS,income,2025-03-31 00:00:00,Gross Profit,95880000000.0
TATACHEM.NS,income,2025-03-31 00:00:00,Cost Of Revenue,52990000000.0
TATACHEM.NS,income,2025-03-31 00:00:00,Total Revenue,148870000000.0
TATACHEM.NS,income,2025-03-31 00:00:00,Operating Revenue,148870000000.0
TATACHEM.NS,income,2024-03-31 00:00:00,Tax Effect Of Unusual Items,-2583000000.0
TATACHEM.NS,income,2024-03-31 00:00:00,Tax Rate For Calcs,0.3
TATACHEM.NS,income,2024-03-31 00:00:00,Normalized EBITDA,32010000000.0
TATACHEM.NS,income,2024-03-31 00:00:00,Total Unusual Items,-8610000000.0
TATACHEM.NS,income,2024-03-31 00:00:00,Total Unusual Items Excluding Goodwill,-8610000000.0
TATACHEM.NS,income,2024-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,2820000000.0
TATACHEM.NS,income,2024-03-31 00:00:00,Reconciled Depreciation,9800000000.0
TATACHEM.NS,income,2024-03-31 00:00:00,Reconciled Cost Of Revenue,53740000000.0
TATACHEM.NS,income,2024-03-31 00:00:00,EBITDA,23400000000.0
TATACHEM.NS,income,2024-03-31 00:00:00,EBIT,13600000000.0
TATACHEM.NS,income,2024-03-31 00:00:00,Net Interest Income,-5300000000.0
TATACHEM.NS,income,2024-03-31 00:00:00,Interest Expense,5300000000.0
TATACHEM.NS,income,2024-03-31 00:00:00,Interest Income,1410000000.0
TATACHEM.NS,income,2024-03-31 00:00:00,Normalized Income,8847000000.0
TATACHEM.NS,income,2024-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,2680000000.0
TATACHEM.NS,income,2024-03-31 00:00:00,Total Expenses,135540000000.0
TATACHEM.NS,income,2024-03-31 00:00:00,Rent Expense Supplemental,420000000.0
TATACHEM.NS,income,2024-03-31 00:00:00,Diluted Average Shares,254752852.0
TATACHEM.NS,income,2024-03-31 00:00:00,Basic Average Shares,254752852.0
TATACHEM.NS,income,2024-03-31 00:00:00,Diluted EPS,10.52
TATACHEM.NS,income,2024-03-31 00:00:00,Basic EPS,10.52
TATACHEM.NS,income,2024-03-31 00:00:00,Diluted NI Availto Com Stockholders,2680000000.0
TATACHEM.NS,income,2024-03-31 00:00:00,Net Income Common Stockholders,2680000000.0
TATACHEM.NS,income,2024-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
TATACHEM.NS,income,2024-03-31 00:00:00,Net Income,2680000000.0
TATACHEM.NS,income,2024-03-31 00:00:00,Minority Interests,-1670000000.0
TATACHEM.NS,income,2024-03-31 00:00:00,Net Income Including Noncontrolling Interests,4350000000.0
TATACHEM.NS,income,2024-03-31 00:00:00,Net Income Discontinuous Operations,-140000000.0
TATACHEM.NS,income,2024-03-31 00:00:00,Net Income Continuous Operations,4490000000.0
TATACHEM.NS,income,2024-03-31 00:00:00,Tax Provision,3810000000.0
TATACHEM.NS,income,2024-03-31 00:00:00,Pretax Income,8300000000.0
TATACHEM.NS,income,2024-03-31 00:00:00,Other Non Operating Income Expenses,2860000000.0
TATACHEM.NS,income,2024-03-31 00:00:00,Special Income Charges,-8610000000.0
TATACHEM.NS,income,2024-03-31 00:00:00,Other Special Charges,8610000000.0
TATACHEM.NS,income,2024-03-31 00:00:00,Write Off,270000000.0
TATACHEM.NS,income,2024-03-31 00:00:00,Impairment Of Capital Assets,9470000000.0
TATACHEM.NS,income,2024-03-31 00:00:00,Restructuring And Mergern Acquisition,
TATACHEM.NS,income,2024-03-31 00:00:00,Net Non Operating Interest Income Expense,-5300000000.0
TATACHEM.NS,income,2024-03-31 00:00:00,Total Other Finance Cost,1000000000.0
TATACHEM.NS,income,2024-03-31 00:00:00,Interest Expense Non Operating,5300000000.0
TATACHEM.NS,income,2024-03-31 00:00:00,Interest Income Non Operating,1410000000.0
TATACHEM.NS,income,2024-03-31 00:00:00,Operating Income,18670000000.0
TATACHEM.NS,income,2024-03-31 00:00:00,Operating Expense,81800000000.0
TATACHEM.NS,income,2024-03-31 00:00:00,Other Operating Expenses,30720000000.0
TATACHEM.NS,income,2024-03-31 00:00:00,Depreciation And Amortization In Income Statement,9800000000.0
TATACHEM.NS,income,2024-03-31 00:00:00,Amortization,1130000000.0
TATACHEM.NS,income,2024-03-31 00:00:00,Depreciation Income Statement,9800000000.0
TATACHEM.NS,income,2024-03-31 00:00:00,Selling General And Administration,22680000000.0
TATACHEM.NS,income,2024-03-31 00:00:00,Selling And Marketing Expense,22680000000.0
TATACHEM.NS,income,2024-03-31 00:00:00,General And Administrative Expense,1230000000.0
TATACHEM.NS,income,2024-03-31 00:00:00,Rent And Landing Fees,420000000.0
TATACHEM.NS,income,2024-03-31 00:00:00,Gross Profit,100470000000.0
TATACHEM.NS,income,2024-03-31 00:00:00,Cost Of Revenue,53740000000.0
TATACHEM.NS,income,2024-03-31 00:00:00,Total Revenue,154210000000.0
TATACHEM.NS,income,2024-03-31 00:00:00,Operating Revenue,154210000000.0
TATACHEM.NS,income,2023-03-31 00:00:00,Tax Effect Of Unusual Items,36788321.167883
TATACHEM.NS,income,2023-03-31 00:00:00,Tax Rate For Calcs,0.105109
TATACHEM.NS,income,2023-03-31 00:00:00,Normalized EBITDA,39220000000.0
TATACHEM.NS,income,2023-03-31 00:00:00,Total Unusual Items,350000000.0
TATACHEM.NS,income,2023-03-31 00:00:00,Total Unusual Items Excluding Goodwill,350000000.0
TATACHEM.NS,income,2023-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,23350000000.0
TATACHEM.NS,income,2023-03-31 00:00:00,Reconciled Depreciation,8920000000.0
TATACHEM.NS,income,2023-03-31 00:00:00,Reconciled Cost Of Revenue,41490000000.0
TATACHEM.NS,income,2023-03-31 00:00:00,EBITDA,39570000000.0
TATACHEM.NS,income,2023-03-31 00:00:00,EBIT,30650000000.0
TATACHEM.NS,income,2023-03-31 00:00:00,Net Interest Income,-3310000000.0
TATACHEM.NS,income,2023-03-31 00:00:00,Interest Expense,3250000000.0
TATACHEM.NS,income,2023-03-31 00:00:00,Interest Income,750000000.0
TATACHEM.NS,income,2023-03-31 00:00:00,Normalized Income,23036788321.167885
TATACHEM.NS,income,2023-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,23170000000.0
TATACHEM.NS,income,2023-03-31 00:00:00,Total Expenses,136890000000.0
TATACHEM.NS,income,2023-03-31 00:00:00,Rent Expense Supplemental,500000000.0
TATACHEM.NS,income,2023-03-31 00:00:00,Diluted Average Shares,254756278.0
TATACHEM.NS,income,2023-03-31 00:00:00,Basic Average Shares,254756278.0
TATACHEM.NS,income,2023-03-31 00:00:00,Diluted EPS,90.95
TATACHEM.NS,income,2023-03-31 00:00:00,Basic EPS,90.95
TATACHEM.NS,income,2023-03-31 00:00:00,Diluted NI Availto Com Stockholders,23170000000.0
TATACHEM.NS,income,2023-03-31 00:00:00,Net Income Common Stockholders,23170000000.0
TATACHEM.NS,income,2023-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
TATACHEM.NS,income,2023-03-31 00:00:00,Net Income,23170000000.0
TATACHEM.NS,income,2023-03-31 00:00:00,Minority Interests,-1170000000.0
TATACHEM.NS,income,2023-03-31 00:00:00,Net Income Including Noncontrolling Interests,24340000000.0
TATACHEM.NS,income,2023-03-31 00:00:00,Net Income Discontinuous Operations,-180000000.0
TATACHEM.NS,income,2023-03-31 00:00:00,Net Income Continuous Operations,24520000000.0
TATACHEM.NS,income,2023-03-31 00:00:00,Tax Provision,2880000000.0
TATACHEM.NS,income,2023-03-31 00:00:00,Pretax Income,27400000000.0
TATACHEM.NS,income,2023-03-31 00:00:00,Other Non Operating Income Expenses,360000000.0
TATACHEM.NS,income,2023-03-31 00:00:00,Special Income Charges,-220000000.0
TATACHEM.NS,income,2023-03-31 00:00:00,Other Special Charges,190000000.0
TATACHEM.NS,income,2023-03-31 00:00:00,Write Off,30000000.0
TATACHEM.NS,income,2023-03-31 00:00:00,Impairment Of Capital Assets,
TATACHEM.NS,income,2023-03-31 00:00:00,Restructuring And Mergern Acquisition,
TATACHEM.NS,income,2023-03-31 00:00:00,Net Non Operating Interest Income Expense,-3310000000.0
TATACHEM.NS,income,2023-03-31 00:00:00,Total Other Finance Cost,810000000.0
TATACHEM.NS,income,2023-03-31 00:00:00,Interest Expense Non Operating,3250000000.0
TATACHEM.NS,income,2023-03-31 00:00:00,Interest Income Non Operating,750000000.0
TATACHEM.NS,income,2023-03-31 00:00:00,Operating Income,29910000000.0
TATACHEM.NS,income,2023-03-31 00:00:00,Operating Expense,95400000000.0
TATACHEM.NS,income,2023-03-31 00:00:00,Other Operating Expenses,42630000000.0
TATACHEM.NS,income,2023-03-31 00:00:00,Depreciation And Amortization In Income Statement,8920000000.0
TATACHEM.NS,income,2023-03-31 00:00:00,Amortization,1090000000.0
TATACHEM.NS,income,2023-03-31 00:00:00,Depreciation Income Statement,7830000000.0
TATACHEM.NS,income,2023-03-31 00:00:00,Selling General And Administration,27470000000.0
TATACHEM.NS,income,2023-03-31 00:00:00,Selling And Marketing Expense,26420000000.0
TATACHEM.NS,income,2023-03-31 00:00:00,General And Administrative Expense,1050000000.0
TATACHEM.NS,income,2023-03-31 00:00:00,Rent And Landing Fees,500000000.0
TATACHEM.NS,income,2023-03-31 00:00:00,Gross Profit,125310000000.0
TATACHEM.NS,income,2023-03-31 00:00:00,Cost Of Revenue,41490000000.0
TATACHEM.NS,income,2023-03-31 00:00:00,Total Revenue,166800000000.0
TATACHEM.NS,income,2023-03-31 00:00:00,Operating Revenue,166800000000.0
TATACHEM.NS,income,2022-03-31 00:00:00,Tax Effect Of Unusual Items,52855428.914217
TATACHEM.NS,income,2022-03-31 00:00:00,Tax Rate For Calcs,0.160168
TATACHEM.NS,income,2022-03-31 00:00:00,Normalized EBITDA,26670000000.0
TATACHEM.NS,income,2022-03-31 00:00:00,Total Unusual Items,330000000.0
TATACHEM.NS,income,2022-03-31 00:00:00,Total Unusual Items Excluding Goodwill,330000000.0
TATACHEM.NS,income,2022-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,12530000000.0
TATACHEM.NS,income,2022-03-31 00:00:00,Reconciled Depreciation,8060000000.0
TATACHEM.NS,income,2022-03-31 00:00:00,Reconciled Cost Of Revenue,32880000000.0
TATACHEM.NS,income,2022-03-31 00:00:00,EBITDA,27000000000.0
TATACHEM.NS,income,2022-03-31 00:00:00,EBIT,18940000000.0
TATACHEM.NS,income,2022-03-31 00:00:00,Net Interest Income,-1880000000.0
TATACHEM.NS,income,2022-03-31 00:00:00,Interest Expense,2270000000.0
TATACHEM.NS,income,2022-03-31 00:00:00,Interest Income,1150000000.0
TATACHEM.NS,income,2022-03-31 00:00:00,Normalized Income,12252855428.914217
TATACHEM.NS,income,2022-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,12580000000.0
TATACHEM.NS,income,2022-03-31 00:00:00,Total Expenses,109790000000.0
TATACHEM.NS,income,2022-03-31 00:00:00,Rent Expense Supplemental,430000000.0
TATACHEM.NS,income,2022-03-31 00:00:00,Diluted Average Shares,254756278.0
TATACHEM.NS,income,2022-03-31 00:00:00,Basic Average Shares,254756278.0
TATACHEM.NS,income,2022-03-31 00:00:00,Diluted EPS,49.37
TATACHEM.NS,income,2022-03-31 00:00:00,Basic EPS,49.37
TATACHEM.NS,income,2022-03-31 00:00:00,Diluted NI Availto Com Stockholders,12580000000.0
TATACHEM.NS,income,2022-03-31 00:00:00,Net Income Common Stockholders,12580000000.0
TATACHEM.NS,income,2022-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
TATACHEM.NS,income,2022-03-31 00:00:00,Net Income,12580000000.0
TATACHEM.NS,income,2022-03-31 00:00:00,Minority Interests,-1470000000.0
TATACHEM.NS,income,2022-03-31 00:00:00,Net Income Including Noncontrolling Interests,14050000000.0
TATACHEM.NS,income,2022-03-31 00:00:00,Net Income Discontinuous Operations,50000000.0
TATACHEM.NS,income,2022-03-31 00:00:00,Net Income Continuous Operations,14000000000.0
TATACHEM.NS,income,2022-03-31 00:00:00,Tax Provision,2670000000.0
TATACHEM.NS,income,2022-03-31 00:00:00,Pretax Income,16670000000.0
TATACHEM.NS,income,2022-03-31 00:00:00,Other Non Operating Income Expenses,390000000.0
TATACHEM.NS,income,2022-03-31 00:00:00,Special Income Charges,-250000000.0
TATACHEM.NS,income,2022-03-31 00:00:00,Other Special Charges,70000000.0
TATACHEM.NS,income,2022-03-31 00:00:00,Write Off,180000000.0
TATACHEM.NS,income,2022-03-31 00:00:00,Impairment Of Capital Assets,
TATACHEM.NS,income,2022-03-31 00:00:00,Restructuring And Mergern Acquisition,110400000.0
TATACHEM.NS,income,2022-03-31 00:00:00,Net Non Operating Interest Income Expense,-1880000000.0
TATACHEM.NS,income,2022-03-31 00:00:00,Total Other Finance Cost,760000000.0
TATACHEM.NS,income,2022-03-31 00:00:00,Interest Expense Non Operating,2270000000.0
TATACHEM.NS,income,2022-03-31 00:00:00,Interest Income Non Operating,1150000000.0
TATACHEM.NS,income,2022-03-31 00:00:00,Operating Income,15380000000.0
TATACHEM.NS,income,2022-03-31 00:00:00,Operating Expense,76910000000.0
TATACHEM.NS,income,2022-03-31 00:00:00,Other Operating Expenses,31130000000.0
TATACHEM.NS,income,2022-03-31 00:00:00,Depreciation And Amortization In Income Statement,8060000000.0
TATACHEM.NS,income,2022-03-31 00:00:00,Amortization,1040000000.0
TATACHEM.NS,income,2022-03-31 00:00:00,Depreciation Income Statement,7020000000.0
TATACHEM.NS,income,2022-03-31 00:00:00,Selling General And Administration,22870000000.0
TATACHEM.NS,income,2022-03-31 00:00:00,Selling And Marketing Expense,22050000000.0
TATACHEM.NS,income,2022-03-31 00:00:00,General And Administrative Expense,820000000.0
TATACHEM.NS,income,2022-03-31 00:00:00,Rent And Landing Fees,430000000.0
TATACHEM.NS,income,2022-03-31 00:00:00,Gross Profit,92290000000.0
TATACHEM.NS,income,2022-03-31 00:00:00,Cost Of Revenue,32880000000.0
TATACHEM.NS,income,2022-03-31 00:00:00,Total Revenue,125170000000.0
TATACHEM.NS,income,2022-03-31 00:00:00,Operating Revenue,125170000000.0
TATACHEM.NS,income,2021-03-31 00:00:00,Tax Effect Of Unusual Items,
TATACHEM.NS,income,2021-03-31 00:00:00,Tax Rate For Calcs,
TATACHEM.NS,income,2021-03-31 00:00:00,Normalized EBITDA,
TATACHEM.NS,income,2021-03-31 00:00:00,Total Unusual Items,
TATACHEM.NS,income,2021-03-31 00:00:00,Total Unusual Items Excluding Goodwill,
TATACHEM.NS,income,2021-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,
TATACHEM.NS,income,2021-03-31 00:00:00,Reconciled Depreciation,
TATACHEM.NS,income,2021-03-31 00:00:00,Reconciled Cost Of Revenue,
TATACHEM.NS,income,2021-03-31 00:00:00,EBITDA,
TATACHEM.NS,income,2021-03-31 00:00:00,EBIT,
TATACHEM.NS,income,2021-03-31 00:00:00,Net Interest Income,
TATACHEM.NS,income,2021-03-31 00:00:00,Interest Expense,
TATACHEM.NS,income,2021-03-31 00:00:00,Interest Income,747600000.0
TATACHEM.NS,income,2021-03-31 00:00:00,Normalized Income,
TATACHEM.NS,income,2021-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,
TATACHEM.NS,income,2021-03-31 00:00:00,Total Expenses,
TATACHEM.NS,income,2021-03-31 00:00:00,Rent Expense Supplemental,519200000.0
TATACHEM.NS,income,2021-03-31 00:00:00,Diluted Average Shares,254756278.0
TATACHEM.NS,income,2021-03-31 00:00:00,Basic Average Shares,254756278.0
TATACHEM.NS,income,2021-03-31 00:00:00,Diluted EPS,10.06
TATACHEM.NS,income,2021-03-31 00:00:00,Basic EPS,10.06
TATACHEM.NS,income,2021-03-31 00:00:00,Diluted NI Availto Com Stockholders,
TATACHEM.NS,income,2021-03-31 00:00:00,Net Income Common Stockholders,
TATACHEM.NS,income,2021-03-31 00:00:00,Otherunder Preferred Stock Dividend,
TATACHEM.NS,income,2021-03-31 00:00:00,Net Income,
TATACHEM.NS,income,2021-03-31 00:00:00,Minority Interests,
TATACHEM.NS,income,2021-03-31 00:00:00,Net Income Including Noncontrolling Interests,
TATACHEM.NS,income,2021-03-31 00:00:00,Net Income Discontinuous Operations,
TATACHEM.NS,income,2021-03-31 00:00:00,Net Income Continuous Operations,
TATACHEM.NS,income,2021-03-31 00:00:00,Tax Provision,
TATACHEM.NS,income,2021-03-31 00:00:00,Pretax Income,
TATACHEM.NS,income,2021-03-31 00:00:00,Other Non Operating Income Expenses,
TATACHEM.NS,income,2021-03-31 00:00:00,Special Income Charges,
TATACHEM.NS,income,2021-03-31 00:00:00,Other Special Charges,
TATACHEM.NS,income,2021-03-31 00:00:00,Write Off,1700000.0
TATACHEM.NS,income,2021-03-31 00:00:00,Impairment Of Capital Assets,
TATACHEM.NS,income,2021-03-31 00:00:00,Restructuring And Mergern Acquisition,
TATACHEM.NS,income,2021-03-31 00:00:00,Net Non Operating Interest Income Expense,
TATACHEM.NS,income,2021-03-31 00:00:00,Total Other Finance Cost,814900000.0
TATACHEM.NS,income,2021-03-31 00:00:00,Interest Expense Non Operating,
TATACHEM.NS,income,2021-03-31 00:00:00,Interest Income Non Operating,747600000.0
TATACHEM.NS,income,2021-03-31 00:00:00,Operating Income,
TATACHEM.NS,income,2021-03-31 00:00:00,Operating Expense,
TATACHEM.NS,income,2021-03-31 00:00:00,Other Operating Expenses,
TATACHEM.NS,income,2021-03-31 00:00:00,Depreciation And Amortization In Income Statement,
TATACHEM.NS,income,2021-03-31 00:00:00,Amortization,1175000000.0
TATACHEM.NS,income,2021-03-31 00:00:00,Depreciation Income Statement,
TATACHEM.NS,income,2021-03-31 00:00:00,Selling General And Administration,
TATACHEM.NS,income,2021-03-31 00:00:00,Selling And Marketing Expense,
TATACHEM.NS,income,2021-03-31 00:00:00,General And Administrative Expense,631700000.0
TATACHEM.NS,income,2021-03-31 00:00:00,Rent And Landing Fees,519200000.0
TATACHEM.NS,income,2021-03-31 00:00:00,Gross Profit,
TATACHEM.NS,income,2021-03-31 00:00:00,Cost Of Revenue,
TATACHEM.NS,income,2021-03-31 00:00:00,Total Revenue,
TATACHEM.NS,income,2021-03-31 00:00:00,Operating Revenue,
